SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

$RARI is an ERC-20 token that controls the RARI Foundation treasury and governs the Rarible protocol and RARI Chain. The token was issued in 2020 with a max. supply of 25 million $RARI.

Rarible

Rarible is generating significant social media buzz among retail traders who are attracted to its ultra-low circulating supply and potential for rapid volatility. Community members are actively debating the token's long-term utility versus its speculative appeal, frequently highlighting its scarcity as a primary catalyst for potential price appreciation.

EOG Resources, Inc. engages in the exploration, development, production and marketing of crude oil and natural gas. It operates through the United States, Trinidad, and Other International geographical segments. The Other International segment includes China and Canada operations. The company was founded in 1985 and is headquartered in Houston, TX.

EOG Resources, Inc.

EOG Resources is capturing investor attention following a significant $5.6 billion acquisition of Encino Acquisition Partners in the Utica Shale, a move that aims to bolster production capacity and long-term shareholder value. Community discussions remain focused on the company's operational discipline and dividend reliability as investors weigh its aggressive growth strategy against the backdrop of fluctuating energy commodity prices.

Pump.fun

The community is actively discussing the Pump.fun ecosystem and its associated tokens, emphasizing a culture of consistent dollar-cost averaging and organic community growth despite market volatility. Participants are heavily focused on meme-driven momentum, viral marketing strategies, and potential long-term value within the Solana-based token landscape.

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.

Clene Inc

Clene Inc. is currently a focal point for investors as the community anticipates critical upcoming data regarding biomarker analysis and potential FDA accelerated approval pathways for its ALS candidate, CNM-Au8. Discussion is heavily focused on the company's regulatory roadmap, the impact of recent insider selling, and the broader context of how emerging biomarker evidence could influence the stock's long-term valuation.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle is experiencing significant market volatility as investors weigh the company's aggressive expansion and AI-driven personalization against concerns over sluggish same-store sales and rising food costs. While some in the community highlight the chain's resilience as a fast-casual staple, many are actively debating the leadership's strategy and the impact of recent price increases on the core customer base.

Oxford Lane Capital Corp. is a closed-end management investment company, which engages in investing in debt and equity tranches of collateralized loan obligation vehicles. The company was founded on June 9, 2010 and is headquartered in Greenwich, CT.

Oxford Lane Capital Corp

Oxford Lane Capital is seeing intense community debate as investors grapple with the recent 50% dividend cut, which management implemented to prioritize NAV stability and reinvestment in CLO assets. While some shareholders are calling it a capitulation event and expressing deep frustration over the persistent share price decline, others are using the pullback to add to positions, betting that the reduced payout will ultimately stabilize the fund's long-term performance.

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Elevance Health Inc

Elevance Health (ELV) is currently under intense scrutiny as investors weigh recent strategic cutbacks to its Medicare Advantage footprint against a backdrop of ongoing sector-wide margin pressure and regulatory uncertainty. Community sentiment is deeply divided, with many traders viewing the stock as an undervalued opportunity for a long-term rebound, while others express frustration over its recent price volatility and lack of momentum.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

The DJT stock is currently at the center of heated online debate as community members clash over the administration's military actions in the Middle East and the resulting impact on the global economy. Investors and critics alike are actively discussing recent reports of downed aircraft, questions regarding the administration's strategic goals, and the potential long-term financial consequences of the ongoing conflict.

Roundhill ETF Trust - Roundhill Ether Covered Call Strategy ETF

oundhill Ether Covered Call Strategy ETF

The YETH ETF is currently in the spotlight as investors navigate its transition to a weekly distribution model while balancing potential for consistent income against the underlying volatility of Ethereum. Community members are actively debating the fund's NAV performance and comparing its distribution yields to broader crypto-linked assets, with many split between using it as a tactical income tool or a long-term holding.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group is experiencing significant volatility as investors weigh the company's mixed quarterly results, fleet management strategy, and the ongoing impact of high debt levels on its future outlook. The community remains sharply divided, with intense debate between those anticipating a major short squeeze and others warning of a structural downturn due to disappointing financial metrics.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Contineum Therapeutics (NASDAQ:CTNM) Trading 8.7% Higher - Still a Buy?

Contineum Therapeutics (NASDAQ:CTNM) Trading 8.7% Higher - Still a Buy...

Contineum Therapeutics, Inc. (NASDAQ:CTNM) Receives Consensus Rating of "Moderate Buy" from Analysts

Contineum Therapeutics, Inc. (NASDAQ:CTNM - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the six research firms that are presently covering the firm, MarketBeat...

Contineum Therapeutics, Inc. $CTNM Shares Sold by Baker BROS. Advisors LP

Baker BROS. Advisors LP decreased its stake in shares of Contineum Therapeutics, Inc. (NASDAQ:CTNM - Free Report) by 75.1% during the 3rd quarter, according to the company in its most recent filing...

Contineum Therapeutics Highlights PIPE-791 IPF Trial, J&J-Backed PIPE-307 Catalysts at Leerink Conference

Executives from Contineum Therapeutics (NASDAQ:CTNM) outlined the company's clinical priorities and upcoming catalysts during a presentation at the Leerink Global Healthcare Conference, emphasizing a...

Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation...

Contineum Therapeutics (NASDAQ:CTNM) Price Target Raised to $20.00 at Robert W. Baird

Robert W. Baird raised their price target on shares of Contineum Therapeutics from $14.00 to $20.00 and gave the stock an "outperform" rating in a research note on Friday...

Contineum Therapeutics (NASDAQ:CTNM) Posts Earnings Results, Beats Expectations By $0.01 EPS

Contineum Therapeutics (NASDAQ:CTNM - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.49) earnings per share (EPS) for the quarter, topping the consensus...

Contineum Therapeutics Reports Fourth-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones

Contineum Therapeutics to Present at the 2026 Leerink Partners Global Healthcare Conference

Beat the Market the Zacks Way: Contineum Therapeutics, Suzano, PepsiCo in Focus

Contineum Therapeutics surged 27% after a Zacks Rank upgrade, spotlighting how Zacks' strategies are beating a volatile market.

Contineum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing novel, oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need. The company was founded by Daniel S. Lorrain on May 9, 2017 and is headquartered in San Diego, CA.

Contineum Therapeutics Inc. - Ordinary Shares - Class A

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

CTNM
Contineum Therapeutics Inc. - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CTNM News

CTNMContineum Therapeutics Inc. - Ordinary Shares - Class A